Diabetes treatment is constantly advancing, with new therapeutic options emerging to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the https://sashamjpc679092.wikigop.com/27915/novel_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment